United States · FDA National Drug Code directory
Imatinib Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-7630_0cdf555d-a2ab-481a-9414-9aea7884298e
- Product NDC
- 0093-7630
- Form
- TABLET, FILM COATED
- Composition / generic term
- Imatinib Mesylate
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160804
- Source listing expiry
- 20271231
Source-listed ingredients
- IMATINIB MESYLATE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (0093-7630-56) · 0093-7630-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →